Allergic disorders represent a significant global health concern, with prostaglandins playing a pivotal role in their onset and progression. This thesis delves into the intricate roles of DP1 and DP2 receptors in allergic reactions, offering detailed insights into their molecular structures and the consequent signaling pathways. The therapeutic potential of DP1 and DP2 antagonists has been underscored, revealing promising avenues for future allergic treatments. As we continue to advance in this realm, the DP1 and DP2 receptors stand out as beacons of hope, paving the way for innovative treatments that could transform the landscape of allergic disorder management.